99 results on '"Muyldermans G"'
Search Results
2. Characterization of structural and non-structural proteins of hog cholera virus by means of monoclonal antibodies
3. Polymerase chain reaction-mediated cloning and in vitro translation of the genes coding for the structural proteins of hog cholera virus
4. Production and characterization of monoclonal antibodies against hog cholera virus (Alfort 187 strain)
5. Recombinant antigens of Ureaplasma spp. as a possible tool for a serological test
6. Evolution of primary resistance in Belgium (1995–2000)
7. Blinded, multicenter quality control study for the quantification of human immunodeficiency virus type 1 RNA in plasma by the Belgian AIDS reference laboratories
8. Serological and antigenical findings indicating pestivirus in man
9. HIV-1 resistance and trend analysis in newly diagnosed patients in Belgium
10. Hepatitis C virus (HCV) prevalence estimation in the adult general population in Belgium : a meta-analysis.
11. Diagnostic hepatitis C testing of people in treatment for substance use disorders in Belgium between 2011 and 2014 : a cross-sectional study.
12. Production of recombinant antigens of Ureaplasma parvum serotype 3 and 6 for the development of a serological assay
13. Polymorphism of Belgian Bordetella pertussis isolates
14. Blinded, multicenter quality control study for the quantification of Human Immunodeficiency virus type1 RNA in plasma by the Belgian AIDS Reference laboratories
15. Blinded, multicenter quality control study for the quantification of human immunodeficiency virus type 1 RNA in plasma by the Belgian AIDS reference laboratories
16. External quality assessment for molecular detection of Bordetella pertussis in European laboratories.
17. Case finding of Influenza A(H1N1)2009 in Belgium in the early pandemic
18. Confirmation diagnosis of influenza A(H1N1)2009 by Belgian sentinel laboratories during the epidemic phase
19. The Impact of Individual Human Immunodeficiency Virus Type 1 Protease Mutations on Drug Susceptibility Is Highly Influenced by Complex Interactions with the Background Protease Sequence
20. Production of Recombinant Antigens of Ureaplasma parvum Serotypes 3 and 6 for Development of a Serological Assay
21. Reproducibility of a high-throughput HIV-1 genotypic resistance assay over time (2001–2007)
22. Reduced susceptibility to lamivudine and emtricitabine associated with the novel K66N mutation in HIV-1 reverse transcriptase
23. External Quality Assessment for Molecular Detection of Bordetella pertussis in European Laboratories
24. Recovery of Mycobacterium elephantis from Sputum of a Patient in Belgium
25. Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene.
26. Prevalence of Genotypic Resistance among Antiretroviral Drug-Naive HIV-1-Infected Patients in Belgium
27. Identification of New Verocytotoxin Type 2 Variant B-Subunit Genes in Human and Animal Escherichia coli Isolates
28. False-Negative PCR in a Case of Haemophilus influenzae Serotype e Meningitis in a Vaccinated Child
29. Neonatal infections with Pseudomonas aeruginosa associated with a water-bath used to thaw fresh frozen plasma
30. Application of the Amplification Refractory Mutation System to differentiate Ureaplasma urealyticum serotypes
31. Detection of Bartonella quintana by PCR in an HIV-seropositive patient with bacillary angiomatosis
32. Evaluation of polymerase chain reaction as a diagnostic tool in the prenatal diagnosis of congenital toxoplasmosis
33. Production of Recombinant Antigens of Ureaplasma parvumSerotypes 3 and 6 for Development of a Serological Assay
34. External Quality Assessment for Molecular Detection of Bordetella pertussisin European Laboratories
35. Development of an enzyme-linked immunosorbent assay for serotyping ureaplasma urealyticum strains using monoclonal antibodies.
36. Development of monoclonal antibodies against Ureaplasma urealyticum serotypes and their use for serotyping clinical isolates.
37. Identification of New Verocytotoxin Type 2 Variant B-Subunit Genes in Human and Animal Escherichia coliIsolates
38. Hepatitis C virus (HCV) prevalence estimation in the adult general population in Belgium : a meta-analysis
39. Hepatitis C virus (HCV) prevalence estimation in the adult general population in Belgium : a meta-analysis
40. Prevalence and trends of primary drug resistance in newly HIV-1 diagnosed patients in Belgium
41. Establishment and reinforcement of the national reference centers for human microbiology in Belgium
42. Competitive antagonists of the action of diphtheria toxin in HeLa cells
43. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene
44. Recovery of Mycobacterium elephantisfrom Sputum of a Patient in Belgium
45. A multicentre interventional study to assess blood-borne viral infections in Belgian prisons.
46. Low hepatitis C prevalence in Belgium: implications for treatment reimbursement and scale up.
47. Distribution of HCV genotypes in Belgium from 2008 to 2015.
48. Surveillance of Infectious Diseases by the Sentinel Laboratory Network in Belgium: 30 Years of Continuous Improvement.
49. Assessing the sensitivity and representativeness of the Belgian Sentinel Network of Laboratories using test reimbursement data.
50. Correction: Establishment and reinforcement of the National Reference Centers for Human Microbiology in Belgium.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.